Catalyst Pharmaceuticals Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Catalyst Pharmaceuticals Inc développe et commercialise des médicaments pour le traitement de maladies neurologiques rares et compliquées, notamment la myasthénie grave.
$ 29.44
0.58 %
Catalyst Pharmaceuticals Inc
$
29.44
0.58 %
Catalyst Pharmaceuticals Inc développe et commercialise des médicaments pour le traitement de maladies neurologiques rares et compliquées, notamment la myasthénie grave.
Price history of Catalyst Pharmaceuticals Inc
Price history of Catalyst Pharmaceuticals Inc
Performance & Momentum
6 Months
31.23 %
1 Year
17.67 %
3 Years
64.68 %
5 Years
482.55 %
Similar stocks to Catalyst Pharmaceuticals Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases